Literature DB >> 4603170

Relationship of serum complement levels to events of the malarial paroxysm.

F A Neva, W A Howard, R H Glew, W A Krotoski, A A Gam, W E Collins, J P Atkinson, M M Frank.   

Abstract

Malarial paroxysms due to Plasmodium vivax were studied for alterations in whole serum complement (C') and certain C' components. The objective was to relate C' values with events of the parasite cycle during schizogony and with the febrile pattern. Substantial decreases in C' were found in 9 of 18 paroxysms studied during relapse. In contrast, only one of 22 paroxysms occuring during the primary attack was associated with a striking depression in C', and this case exhibited certain characteristics of a relapse paroxysm. The mean change in C' levels during paroxysms in relapse (-23%) was significantly different from paroxysms of the primary attack (-2%). Depletion of C' was associated directly with degree of parasitemia and presence of complement-fixing (CF) antibody. Lowest levels of C' were found within a few hours after completion of schizont repture and peak fever. C4 levels reflected changes in whole serum C' and appeared to be a more sensitive indicator of C' alterations during malaria. While the alterations in C4 as well as C1 and C2 indicated that the classical C' pathway was involved, some preliminary results showed little or no depletion of late components, C3 and C6. Overall results are compatible with C' activation and depletion during or soon after schizont repture if parasite density is sufficiently high and if CF antibody is present.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4603170      PMCID: PMC301573          DOI: 10.1172/JCI107781

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Precise standardization of reagents for complement fixation.

Authors:  J F KENT; E H FIFE
Journal:  Am J Trop Med Hyg       Date:  1963-01       Impact factor: 2.345

2.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.

Authors:  M M Frank; J S Sergent; M A Kane; D W Alling
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

Review 3.  The complement system of man (second of four parts).

Authors:  S Ruddy; I Gigli; K F Austen
Journal:  N Engl J Med       Date:  1972-09-14       Impact factor: 91.245

4.  Malaria: host-defense mechanisms and complications.

Authors:  F A Neva; J N Sheagren; N R Shulman; C J Canfield
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

Review 5.  Complement in human disease.

Authors:  P H Schur; K F Austen
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

6.  Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.

Authors:  T A Gaither; M M Frank
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

7.  The application of the indirect haemagglutination test in recent studies on the immuno-epidemiology of human malaria and the immune response in experimental malaria.

Authors:  R S Desowitz; J J Saave; B Stein
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

8.  Complement in acute experimental malaria. II. Alterations in the components of complement.

Authors:  N R Cooper; B J Fogel
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

9.  Complement in acute experimental malaria. I. Total hemolytic activity.

Authors:  B J Fogel; A E Von Doenhoff; N R Cooper; E H Fife
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

10.  Properties of protective malarial antibody.

Authors:  S Cohen; G A Butcher
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

View more
  11 in total

1.  Complement changes in falciparum malaria infection.

Authors:  P Phanuphak; M Hanvanich; R Sakulramrung; P Moollaor; V Sitprija; D Phanthumkosol
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

2.  Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria.

Authors:  C Adam; M Géniteau; M Gougerot-Pocidalo; P Verroust; J Lebras; C Gibert; L Morel-Maroger
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

Review 3.  Malaria: immunity and prospects for vaccination.

Authors:  M Hommel
Journal:  West J Med       Date:  1981-10

4.  Complement in experimental Trypanosoma lewisi infection of rats.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

5.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Placental pathologic changes in malaria. A histologic and ultrastructural study.

Authors:  P R Walter; Y Garin; P Blot
Journal:  Am J Pathol       Date:  1982-12       Impact factor: 4.307

Review 7.  Pathogenesis of malaria revisited.

Authors:  Prasad Dasari; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2012-09-07       Impact factor: 3.402

8.  Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence.

Authors:  Yvonne Azasi; Leanne M Low; Ashley N Just; Sai S R Raghavan; Christian W Wang; Paola Valenzuela-Leon; J Alexandra Rowe; Joseph D Smith; Thomas Lavstsen; Louise Turner; Eric Calvo; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

9.  Humoral immunostimulation. IV. Role of complement.

Authors:  W T Shearer; J P Atkinson; M M Frank; C W Parker
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

10.  Complement activation by merozoite antigens of Plasmodium falciparum.

Authors:  Jackson C Korir; Nancy K Nyakoe; George Awinda; John N Waitumbi
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.